FDA clears IND for phase I trial of PRGN-2012 for recurrent respiratory papillomatosis Jan. 8, 2021 No Comments
Cerecor reports phase II proof-of-concept data for CERC-002 in COVID-19 ARDS Jan. 7, 2021 No Comments
Windtree initiates phase II trial of lucinactant for COVID-19-associated acute lung injury Jan. 7, 2021 No Comments
HY-1702 found to be protective in LPS-induced respiratory distress syndrome in mice Jan. 4, 2021 No Comments
Phase IIb/III trial of Zyesami for respiratory failure in critical COVID-19 completes enrollment Dec. 30, 2020 No Comments
National Institute of Pharmaceutical R&D describes M3 antagonists/beta2-adrenoceptor agonists Dec. 28, 2020 No Comments
RSS